Ultrasound to diagnose a rare liver vessel disorder
Part of Digestive system clinical trials.
This study uses a special ultrasound with a contrast agent to see if it can diagnose PSVD (a rare liver vessel disorder) without a biopsy. It compares people with PSVD to those with cirrhosis to find better, noninvasive ways to detect this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have PSVD (a rare liver blood vessel disorder) or cirrhosis (liver scarring), confirmed by biopsy or other tests.
- You need to have signs of high blood pressure in the liver veins, like enlarged veins in the belly or food pipe, or a past variceal bleed.
- You must be at least 18 years old.
- You cannot have other causes of high liver vein pressure, such as certain rare diseases or past bone marrow transplant.
- You cannot have liver tumors, a TIPS device (a shunt inside the liver), or have had liver or spleen surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to measure blood pressure in the main vein of the liver (portal vein) using an endoscope. It may help doctors better understand and manage liver problems without needing a more invasive procedure.
This study tests whether ultrasound imaging can predict which patients with cirrhosis (scarring of the liver) are at higher risk of dangerous bleeding from enlarged veins in the esophagus. If successful, this could help doctors decide which patients need preventive treatment.
This study tests a new way to measure if a type of blood pressure medicine called non-selective beta-blockers (NSBBs) is helping patients with cirrhosis. It uses a thin, flexible tube with a camera (endoscope) to measure pressures in the liver and a nearby vein. If you have cirrhosis with high pressure in the portal vein but haven't started NSBBs yet, this study may help your doctor decide if the medicine is working for you.
This study tracks people with liver cirrhosis to see how often portal vein thrombosis (a blood clot in the main vein to the liver) occurs and how it can be treated with blood thinners. It aims to improve care for those at risk of these clots.
This trial uses a minimally invasive ultrasound technique to directly measure blood pressure in the liver's main vein. It may help doctors decide if patients with severe scarred livers need medication to prevent variceal bleeding.
This trial looks at people with clinically significant portal hypertension, which is high blood pressure in the liver's blood vessels. It may help find better ways to manage this condition.
Hear when a new Liver Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.